|
Free Research Articles
Citations 1-10 of 689 total displayed.
|
Most recent content
(16 Jul 2009):
|
Extranodal marginal zone lymphoma of the ocular adnexa
- Alexandra Stefanovic and Izidore S. Lossos
Blood 2009; 114: 501-510.
[Abstract]
[Full text]
[PDF]
Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network
- Amin M. Alousi, Daniel J. Weisdorf, Brent R. Logan, Javier Bolaños-Meade, Shelly Carter, Nancy DiFronzo, Marcelo Pasquini, Steven C. Goldstein, Vincent T. Ho, Brandon Hayes-Lattin, John R. Wingard, Mary M. Horowitz, and John E. Levine, on behalf of the Blood and Marrow Transplant Clinical Trials Network
Blood 2009; 114: 511-517.
[Abstract]
[Full text]
[PDF]
Spontaneous regression of chronic lymphocytic leukemia: clinical and biologic features of 9 cases
- Ilaria Del Giudice, Sabina Chiaretti, Simona Tavolaro, Maria Stefania De Propris, Roberta Maggio, Francesca Mancini, Nadia Peragine, Simona Santangelo, Marilisa Marinelli, Francesca Romana Mauro, Anna Guarini, and Robin Foà
Blood 2009; 114: 638-646.
[Abstract]
[Full text]
[PDF]
Imatinib for refractory chronic graft-versus-host disease with fibrotic features
- Attilio Olivieri, Franco Locatelli, Marco Zecca, Adele Sanna, Michele Cimminiello, Roberto Raimondi, Guido Gini, Nicola Mordini, Adriana Balduzzi, Pietro Leoni, Armando Gabrielli, and Andrea Bacigalupo
Blood 2009; 114: 709-718.
[Abstract]
[Full text]
[PDF]
Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease
- Leonardo Magro, Mohamad Mohty, Benoit Catteau, Valérie Coiteux, Patrice Chevallier, Louis Terriou, Jean-Pierre Jouet, and Ibrahim Yakoub-Agha
Blood 2009; 114: 719-722.
[Abstract]
[Full text]
[PDF]
|
Past content
(since May 2004):
|
Red cell genotyping and the future of pretransfusion testing
- David J. Anstee
Blood 2009; 114: 248-256.
[Abstract]
[Full text]
[PDF]
Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin
- Sarit Assouline, Biljana Culjkovic, Eftihia Cocolakis, Caroline Rousseau, Nathalie Beslu, Abdellatif Amri, Stephen Caplan, Brian Leber, Denis-Claude Roy, Wilson H. Miller, Jr, and Katherine L. B. Borden
Blood 2009; 114: 257-260.
[Abstract]
[Full text]
[PDF]
Tyrosine kinase inhibitor–induced platelet dysfunction in patients with chronic myeloid leukemia
- Alfonso Quintás-Cardama, Xin Han, Hagop Kantarjian, and Jorge Cortes
Blood 2009; 114: 261-263.
[Abstract]
[Full text]
[PDF]
Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies
- Qing Lan, Lindsay M. Morton, Bruce Armstrong, Patricia Hartge, Idan Menashe, Tongzhang Zheng, Mark P. Purdue, James R. Cerhan, Yawei Zhang, Andrew Grulich, Wendy Cozen, Meredith Yeager, Theodore R. Holford, Claire M. Vajdic, Scott Davis, Brian Leaderer, Anne Kricker, Maryjean Schenk, Shelia H. Zahm, Nilanjan Chatterjee, Stephen J. Chanock, Nathaniel Rothman, and Sophia S. Wang
Blood 2009; 114: 264-267.
[Abstract]
[Full text]
[PDF]
The molecular basis of hepcidin-resistant hereditary hemochromatosis
- Augustine Fernandes, Gloria C. Preza, Yen Phung, Ivana De Domenico, Jerry Kaplan, Tomas Ganz, and Elizabeta Nemeth
Blood 2009; 114: 437-443.
[Abstract]
[Full text]
[PDF]
|
|
